Effect of Acute Protein Supplementation in Diabetic Patients
Launched by UNIVERSITY OF MALAYA · Mar 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special protein from house crickets might help people with type 2 diabetes manage their blood sugar levels. The main goal is to see if eating house cricket powder can reduce blood sugar spikes after meals and increase insulin response, which is important for controlling diabetes. Participants will be given either house cricket powder, whey protein (a common protein supplement), or a placebo (a substance with no active ingredients) mixed into a chicken-flavored soup. Their blood samples will be taken through a simple finger prick for up to two hours to measure how their blood sugar responds.
To be eligible for this study, participants must be diagnosed with type 2 diabetes and have been taking metformin, a common diabetes medication, for at least six months. However, individuals who are taking other diabetes medications, have food allergies, or have had recent surgeries that could affect their blood sugar response won’t be able to participate. This trial is not yet recruiting participants, but it aims to provide important insights into how different types of protein supplements may help manage diabetes more effectively.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Suffering from type 2 diabetes mellitus (HbA1c \> 6.5%)
- • Consume metformin for at least 6 months
- Exclusion Criteria:
- • Consume other type of anti-diabetic drugs
- • Presenting any food allergy
- • Recent surgery or infections that may affect oral glucose tolerance test
- • Consume other drugs that may affect oral glucose tolerance test
- • Not consuming any anti-diabetic drugs
- • Pre-diabetes (HbA1c 5.7 - 6.4%)
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ashril Yusof, PhD
Principal Investigator
University of Malaya
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported